Skip to search form Skip to main content

Semantic Scholar

All Fields

All Fields
Art
Biology
Business
Computer Science
Chemistry
Economics
Engineering
Environmental Science
Geography
Geology
History
Materials Science
Mathematics
Medicine
Philosophy
Physics
Political Science
Psychology
Sociology

FAQ Contact Us•

GSK2374697

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Recombinant Fusion Proteins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2015

2015

GSK2374697, a long duration glucagon-like peptide-1 (GLP-1) receptor agonist, reduces postprandial circulating endogenous total GLP-1 and peptide YY in healthy subjects.

Jiang Lin, Rebecca J. Hodge, Robin L. O'Connor‐Semmes, Derek J Nunez
Diabetes, obesity & metabolism
2015

We investigated the effects of a long-duration glucagon-like peptide-1 (GLP-1) receptor agonist, GSK2374697, on postprandial… Expand

Is this relevant?

2014

2014

GSK2374697, a novel albumin-binding domain antibody (AlbudAb), extends systemic exposure of exendin-4: first study in humans--PK/PD and safety.

Robin L. O'Connor‐Semmes, J Lin, +4 authors Derek J Nunez
Clinical pharmacology and therapeutics
2014

GSK2374697 is a genetically engineered fusion protein of a human domain antibody to exendin-4. This molecule binds with a high… Expand

Is this relevant?

The Allen Institute for AIProudly built by AI2 with the help of our using these .
Terms of Service•Privacy Policy.

By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License

ACCEPT & CONTINUE